Statistician, Israeli IHD Project, Jerusalem, 1964-1967. Chief statistician 1967-1973

Visiting Associate, Biometrics Research Branch, NHLI, NIH, Bethesda, MD, 1973-75

Head of Statistics, Dept of Research and Sports Medicine, Wingate institute, Nethanya, Israel, 1975-79

Epidemiologist, Heart Institute, Sheba Medical Center, Tel Hashomer, Israel, 1976 (part time)-1986

Head, Section of Epidemiology and Biostatistics, Henry N. Neufeld Cardiac Research Institute, 1986-present.

Visiting Scientist, Office of Biometry and Epidemiology, DECA, NHLBI, NIH, Betehsda, MD, 1991/2

Visiting Professor, Loyola University Chicago Medical center, Department of Preventive Medicine and Epidemiology, Maywood, Il, 1999-2000.

Division of Epidemiology and Preventive Medicine, Sackler Medical Faculty, Tel Aviv University, Israel :

Senior lecturer: 1985-1989
Associate professor, 1989-1994
Professor, 1994-present.
Department chairman (rotating 4-yr position): 1995-99

Chairperson, Academic Council, Zinman College of Sports and Physical education, Nethanya , Israel, 2000-present.
Founding member, Israel Epidemiological Association, 1985

Founding member and first chairperson, Working group on cardiovascular Epidemiology and Preventive cardiology, Israel heart Association, 1997

B.Sc. - 1964 : Mathematics / physics - Hebrew University Jerusalem , Israel.
M.A. - 1966 : Statistics / Hebrew University Jerusalem, Israel
Ph.D. - 1984 : Epidemiology / Tel Aviv University, Tel Aviv, Israel



Cardiovascular Epidemiology.
Biostatistical methods for long-term prospective studies.
Diet, lipids, physical activity and coronary heart disease.
Antihypertensive therapy.
Controlled multicentre clinical trials.



179 articles in peer-reviewed journals, 1971-2002.
Selected paper related only to primary prevention of CHD and Stroke, since 1995:

C. Eaton, J.H. Medalie, S. Flocke, S. Zyzanski, S. Yaari, U. Goldbourt. Self-reported physical activity predicts long-term coronary heart disease death and all-cause mortality: Twenty-one year follow-up of the Israeli Ischemic Heart Disease Study.
Arch Family Med 1995; 4: 323-329.

J.R. Crouse, U. Goldbourt, G. Evans, J. Pinsky, A.R. Sharrett, P. Sorlie, W. Riley, G. Heiss for the ARIC investigators. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) Cohort.
Stroke 1996; 27: 69-75.

Fibrinogen is a predictor of mortality in coronary heart disease patients. Benderly M, Graff E, Reicher-Reiss H, Behar S, Brunner D, Goldbourt U, for the BIP Study Group.
Arterioscler Thromb Vasc Biol 1996;16:351-356.

High-density lipoprotein cholesterol and risk of ischemic strok e mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Tanne D, Yaari S, Goldbourt U.
Stroke 1997;28:83-87.

High-density lipoprotein cholesterol and cardiovascular disease. Goldbourt U.
ISSFAL Bulletin No. 4, 1997; 9-11.

Long-term prognosis of women after myocardial infarction. Benderly M, Behar S, Reicher-Reiss H, Boyko V, Goldbourt U, for the SPRINT Study Group.
Am J Epidemiol 1997;146:153-160.

Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Goldbourt U, Yaari S, Medalie J
Arterioscler Thromb Vasc Biol 1997;17:107-113.

Baseline characteristics of patients participating in the Bezafibrate Infarction Prevention (BIP) study. Goldbourt U, Brunner D, Behar S, Reicher-Reiss H, for the BIP Study Group.
Eur Heart J 1998;19(Suppl H):H42-H47.

Risk profile and prediction of long-term ischemic stroke mortality. A 21- year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Tanne D, Yaari S, Goldbourt.
Circulation 1998;98:1365-1371.

Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease. The BIP Registry. Haim M, Benderly M, Brunner D, Behar S, Graff E, Reicher-Reiss H, Goldbourt U, for the BIP Study.
Circulation 1999;100:475-482.

Tanne D, Benderly M, Goldbourt U, Boyko V, brunner d, Graff E, Reicher- Reiss, H, Shotan A, Mandelzweig L, Behar S. A prospective study of plasma fibrinogen levels and the risk of stroke Among participants in the Bezafibrate Infarction Prevention Study.
Am J Med 2001;111:457-463.

Tanne D, Koren-Morag N, E. Graff, U. Goldbourt. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor.
Circulation 2001;104:2892-2897

Goldbourt U, Tanne D. Body height predicts stroke mortality but not coronary heart disease mortality?
Stroke 2002; 33:743-748.

Koren-Morag N, Tanne D, Graff E, Goldbourt U. Serum cholesterol fractions and ischemic cererbrovascular disease. The bezafibrate infarction prevention (BIP) Study.
In press. Archives of Internal Medicine, May 2002

Pub Med